Insider Transactions in Q3 2025 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
35,000
-22.36%
|
$840,000
$24.0 P/Share
|
|
Sep 24
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+18.28%
|
$315,000
$9.42 P/Share
|
|
Sep 16
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
8,172
-1.99%
|
$171,612
$21.68 P/Share
|
|
Sep 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$126,000
$21.85 P/Share
|
|
Sep 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
|
Sep 10
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
25,000
-17.06%
|
$550,000
$22.0 P/Share
|
|
Sep 10
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.58%
|
$225,000
$9.42 P/Share
|
|
Sep 10
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
20,000
-15.95%
|
$440,000
$22.0 P/Share
|
|
Sep 10
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.76%
|
$100,000
$5.84 P/Share
|
|
Sep 09
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
24,792
-16.95%
|
$495,840
$20.0 P/Share
|
|
Sep 09
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
24,792
+14.49%
|
$198,336
$8.01 P/Share
|
|
Sep 09
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
7,000
-3.29%
|
$140,000
$20.0 P/Share
|
|
Sep 09
2025
|
Mario Alberto Accardi President, Orexin Program |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.3%
|
$40,000
$8.01 P/Share
|
|
Sep 09
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
20,000
-15.95%
|
$400,000
$20.01 P/Share
|
|
Sep 09
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.76%
|
$100,000
$5.84 P/Share
|
|
Aug 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$102,000
$17.23 P/Share
|
|
Aug 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
|
Aug 01
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-0.29%
|
$10,149
$17.17 P/Share
|
|
Jul 29
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
8,322
-3.84%
|
$124,830
$15.23 P/Share
|
|
Jul 25
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.56%
|
$150,000
$15.56 P/Share
|
|
Jul 25
2025
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.03%
|
$30,000
$3.85 P/Share
|
|
Jul 21
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-19.93%
|
$825,000
$15.92 P/Share
|
|
Jul 21
2025
|
Saurabh Saha Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+16.62%
|
$165,000
$3.85 P/Share
|
|
Jul 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$84,000
$14.93 P/Share
|
|
Jul 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|